News

Ozempic cuts kidney-disease risks, research finds Diabetes treatment slows progression of kidney disease and reduces risk of death, study shows Last Updated: May 25, 2024 at 9:10 a.m. ET First ...
People taking Ozempic in a multinational trial experienced a 24 percent reduction in risk of death from cardiovascular and kidney disease compared with those who received a placebo.
Heart disease and chronic kidney disease are strongly linked, Parikh says, and “unfortunately, they are self-reinforcing”. Adding in type 2 diabetes is like throwing “rocket fuel” onto the ...
The study included 3,533 people with kidney disease and Type 2 diabetes, about half of whom took a weekly injection of semaglutide, and half of whom took a weekly placebo shot.
In this trial, which followed more than 3,500 people with type 2 diabetes and chronic kidney disease over an average of 3.4 years, people who took a weekly shot of semaglutide in addition to ...
Ozempic, the drug that was originally approved to treat Type 2 diabetes, has now also been approved by the U.S. Food and Drug Administration to reduce certain risks associated with chronic kidney ...
Novo Nordisk’s blockbuster weight-loss drug cuts the risk of kidney disease-related events in diabetic patients by 24%, according to a new clinical trial conducted by the company.
A new study shows the main ingredient in Ozempic and Wegovy, which already help with diabetes and weight loss, may also dramatic cut the risks from chronic kidney disease.Here to answer your ...
COPENHAGEN, Denmark — Novo Nordisk's widely used diabetes drug Ozempic delayed the progression of chronic kidney disease in diabetes patients, a large late-stage study found, cutting the risk of ...
Novo Nordisk A/S’s diabetes drug Ozempic cut the risk of a range of bad health outcomes linked to kidney disease by 24%, less than analysts had expected.
Ozempic cuts kidney-disease risks, research finds Provided by Dow Jones May 25, 2024, 1:10:00 PM. By Eleanor Laise . Diabetes treatment slows progression of kidney disease and reduces risk of ...